“…In vivo, full-length Nogo-A might undergo transcytosis or proteolytic cleavage, resulting in the release of active fragments such as Nogo-A-Δ20 (Joset et al, 2010;Kempf et al, 2014;Thiede-Stan and Schwab, 2015). In the developing CNS, Nogo-A-Δ20 promotes the migration of neuronal precursors but inhibits primary brain microvascular endothelial cell migration, as well as the spreading of endothelial cells and fibroblasts (Kempf et al, 2014;Mathis et al, 2010;Oertle et al, 2003;Rolando et al, 2012;Schmandke et al, 2013;Walchli et al, 2013). Although Nogo-A-Δ20 and Nogo-66 signal through different receptors, the activation of RhoA is a common intracellular signal step downstream of both inhibitory domains (Joset et al, 2010;Kempf et al, 2014;Montani et al, 2009;Nash et al, 2009).…”